Skip to main content

Day: January 24, 2022

Verde launches P4G shareholder earnings strategy after securing Banco do Brasil financing backed by future sales contracts

BELO HORIZONTE, Brazil, Jan. 24, 2022 (GLOBE NEWSWIRE) — Verde AgriTech Plc (TSX: “NPK”) (OTCQB: “AMHPF”) (“Verde” or the “Company”) is pleased to announce its Paid for Growth (“P4G”) strategy, a cornerstone program aimed at distributing gains to shareholders as a result of the Company’s continued accelerated market expansion. This will be possible thanks to the availability of a transformative source of funding secured by the Company. Previously, financing could only be secured by invoice discounting or guaranteed by capital goods, now Verde’s future sales contracts are accepted as debt collateral. The Company also communicates an expansion to its Cultivando Amor program, a charitable initiative aimed at supporting local rural communities. “In Brazil, no other bank has financed more harvests than Banco do Brasil. In...

Continue reading

Treatment Launches Landmark Doctor Built Digital Health App

VANCOUVER, British Columbia, Jan. 24, 2022 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. Today, Treatment announces the global launch of its much-anticipated Treatment Digital Health App, now available in the Apple App Store. The Treatment Digital Health App is a revolutionary symptom assessment tool, built and continually updated by a global team of doctors and engineers to provide users with highly predictive and accurate insights about their health. Powered by Treatment’s proprietary medical AI engine and their groundbreaking Global Library of Medicine (GLM), the Treatment Digital Health App...

Continue reading

Better Choice Company to Ring New York Stock Exchange Opening Bell Today, January 24th

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, today announced that it will ring The Opening Bell® of the New York Stock Exchange (NYSE) today, Monday January 24, 2022 at 9:30 a.m. ET. The New York Stock Exchange welcomes Better Choice in celebration of its listing under the ticker symbol ‘BTTR’ and the national launch of Halo Elevate™, an innovative new super-premium pet food launching in 2,000+ pet specialty stores this year. Scott Lerner, CEO of Better Choice, commented, “We are excited to celebrate our listing on the New York Stock Exchange by ringing the NYSE opening bell. As we further our efforts in pursuit of the Company’s growth objectives, we are proud to have become a key leader and innovator in the pet products industry....

Continue reading

Opthea Receives A$6.6 m R&D Tax Incentive

MELBOURNE, Australia, Jan. 24, 2022 (GLOBE NEWSWIRE) — Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced that it has received a A$6.6 million (US$4.9 million) research and development (R&D) tax credit from the Australian Taxation Office. The cash incentive is for research and development costs incurred in the 2020/2021 financial year, and represents the amount disclosed in the company’s audited financial statements at 30 June 2021. The R&D tax incentive credit relates to both Australian and eligible overseas expenditure for the development of Opthea’s lead candidate OPT-302. The R&D Tax Incentive is as an Australian Federal Government program under which companies can receive cash...

Continue reading

USI Insurance Services Acquires D&H Risk Services

New Partnership Expands USI’s Texas-based Presence and Expertise VALHALLA, N.Y., Jan. 24, 2022 (GLOBE NEWSWIRE) — USI Insurance Services (“USI”), a world leader in risk management, employee benefit and retirement consulting, today announced the acquisition of Longview, Texas-based D&H Risk Services LLC. Founded in 1936, D&H Risk Services is an independent risk management and employee benefits agency serving businesses and individuals throughout Texas. Terms of the transaction were not disclosed. Commenting on the announcement, Trace Shappell, president, D&H Risk Services, stated: “For more than 80 years, the D&H team has taken pride in delivering quality service and local expertise to our valued clients. By joining forces with USI, we are excited to continue this tradition by offering our clients expanded access...

Continue reading

RadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with Artificial Intelligence

When combined with RadNet’s existing DeepHealth mammography AI division, the two acquisitions provide RadNet with the basis for future offerings for widespread cancer screening programs for the three most prevalent cancers (breast, prostate and lung) Aidence’s AI for chest and lung CT scanning is currently used by customers in seven European countries Aidence’s leading product is pending FDA approval for use in the United States With customers in 20 countries worldwide, Quantib’s solutions for prostate and brain MRI already have FDA 510(k) clearance in the United States and CE mark in Europe Dr. Gregory Sorensen, President of RadNet’s DeepHealth division, will assume leadership responsibility for all of RadNet’s AI initiatives, including those within Aidence and QuantibLOS ANGELES, Jan. 24, 2022 (GLOBE NEWSWIRE) — RadNet, Inc....

Continue reading

Sprague Resources LP Announces Cash Distribution for the Fourth Quarter of 2021 and Earnings Conference Call Schedule

Sprague announces a cash distribution of $0.4338 per unit PORTSMOUTH, N.H., Jan. 24, 2022 (GLOBE NEWSWIRE) — Sprague Resources LP (“Sprague”) (NYSE: SRLP) announced today that the Board of Directors of its general partner, Sprague Resources GP LLC (the “General Partner”), declared a cash distribution of $0.4338 per unit ($1.73 per unit on an annualized basis) for the quarter ended December 31, 2021. The fourth quarter distribution is equal to the previous quarter distribution amount. The announced distribution will be paid on Wednesday, February 9, 2022, to unitholders of record as of the close of business on February 4, 2022. Fourth Quarter and Audited Full Year 2021 Financial Results and Earnings Conference CallSprague will release its fourth quarter and full year 2021 audited financial results before the opening of trading on...

Continue reading

DHT Holdings, Inc. announces that Co-CEO Trygve P. Munthe has decided to retire

Hamilton, Bermuda, January 24, 2022 – DHT Holdings, Inc. (NYSE:DHT) announces that after more than 11 years with the Company and a 35-year long career in shipping, Co-CEO Trygve P. Munthe has decided to retire and leave the Company on April 8, 2022 and return to his native Norway. Erik A. Lind, Chairman of the Board of Directors said: “Trygve, and Co-CEO Svein Moxnes Harfjeld, were the architects and critical contributors in the transformation of DHT from an operating lease tanker company in 2010 to one of the most respected public listed tanker shipping companies with a strong, focused and experienced organization of the highest quality. Together they have executed superbly on our strategy. Trygve leaves DHT in the very capable hands of his business partner Svein alone at its helm. On behalf of the Company and its Board of Directors,...

Continue reading

DSV, 939 – SHARE BUYBACK IN DSV A/S

Company Announcement No. 939 On 26 October 2021, we initiated a share buyback programme, as described in Company Announcement No. 925. According to the programme, the company will in the period from 26 October 2021 to 8 February 2022 purchase own shares up to a maximum value of DKK 5,000 million and no more than 5,000,000 shares, corresponding to 2.08% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.Trading day   Number of shares bought back   Average transaction price   Amount DKK               Accumulated trading for days 1-57 3,032,769   1,476.66   4,478,382,69658: 17 January 2022   18,495   1,364.15   25,229,88659: 18...

Continue reading

Global Polymerase Chain Reaction Market Size [2022-2028] worth USD 13.75 Billion, with 8.4% CAGR

Key Companies in Polymerase Chain Reaction Market are Bio-Rad Laboratories, Inc.,QIAGEN ,Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Abbott, Eppendorf AG, Sysmex Inostics, Thermo Fisher Scientific Inc., BD. Pune, India, Jan. 24, 2022 (GLOBE NEWSWIRE) — The global polymerase chain reaction market size was USD 7.10 billion in 2020. The market is projected to grow from USD 7.80 billion in 2021 to USD 13.75 billion in 2028 at a CAGR of 8.4% in the 2021-2028 period.This information is provided by Fortune Business Insights, in its report, titled, “Polymerase Chain Reaction Market, 2021-2028.”According to our researchers, the growth in occurrence of infectious diseases, cancer, and genetic diseases and the increase in the utilization for diagnosing such conditions is the crucial factor accountable for enhancing the market growth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.